|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-10-12
|
|
pubmed:abstractText |
The current standard local treatment for nonresectable pancreatic carcinoma is radiotherapy (RT) with concurrent 5-fluorouracil (5-FU); however, the optimal schedule for 5-FU administration has not been fully established. In this study, we report on our experience with the combination of RT and continuous infusion 5-FU in a group of patients with locally nonresectable pancreatic carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
736-40
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11597816-Adenocarcinoma,
pubmed-meshheading:11597816-Adult,
pubmed-meshheading:11597816-Aged,
pubmed-meshheading:11597816-Antimetabolites, Antineoplastic,
pubmed-meshheading:11597816-Combined Modality Therapy,
pubmed-meshheading:11597816-Feasibility Studies,
pubmed-meshheading:11597816-Female,
pubmed-meshheading:11597816-Fluorouracil,
pubmed-meshheading:11597816-Humans,
pubmed-meshheading:11597816-Infusions, Intravenous,
pubmed-meshheading:11597816-Male,
pubmed-meshheading:11597816-Middle Aged,
pubmed-meshheading:11597816-Pancreatic Neoplasms,
pubmed-meshheading:11597816-Prospective Studies,
pubmed-meshheading:11597816-Radiotherapy Dosage
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma.
|
|
pubmed:affiliation |
Department of Radiotherapy, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy. staff@radioterapiacro.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
